NCT04610229 2025-06-12
GLIORAD
Azienda USL Reggio Emilia - IRCCS
Phase NA Completed
Clinical Trials
11 trialsNCT06419946 2024-11-19
Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma
Vastra Gotaland Region
Phase 3 Not yet recruiting
NCT05108012 2021-11-22
Nk Cell Therapy for Recurrent Glioblastoma Multiform Patients
Royan Institute
Phase 1 Unknown
NCT04270461 2020-10-22
NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors
Jiujiang University Affiliated Hospital
Phase 1 Withdrawn
NCT04488783 2020-07-28
Potentiation of Chemotherapy in Brain Tumors by Zinc
Sheba Medical Center
Phase NA Unknown
NCT03869242 2019-03-11
NovoTTF-200A
Tel-Aviv Sourasky Medical Center
Phase NA Unknown
NCT02149459 2017-10-27
SMC 0712-13
Sheba Medical Center
Phase 1 Unknown
NCT02029573 2017-08-18
ART
King Fahad Medical City
Phase 2 Completed
NCT02430363 2016-02-24
Evaluation Of The Treatment Effectiveness Of Glioblastoma / Gliosarcoma Through The Suppression Of The PI3K/Akt Pathway In Compared With MK-3475
Medical Research Council
Phase 1/2 Unknown
NCT02443194 2015-12-03
The Effect of Duloxetine on Mood, Quality of Life and Cognitive Functioning in Glioblastoma Patients
Tel-Aviv Sourasky Medical Center
Phase 3 Terminated
NCT01450449 2015-03-24
Short Course vs. Standard Course Radiotherapy in Elderly and/or Frail Patients With Glioblastoma Multiforme
International Atomic Energy Agency
Phase 3 Completed